✦ LIBER ✦

Long-term outcome after allogeneic bone marrow transplantation for hematological malignancies with non-remission status

✍ Scribed by M. Tabata; A. Satake; N. Okura; Y. Yamazaki; A. Toda; K. Nishioka; H. Tanaka; M. Chin; T. Itsukuma; M. Yamaguchi; M. Misawa; S. Kai; H. Hara

Publisher: Springer
Year: 2002
Tongue: English
Weight: 150 KB
Volume: 81
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-002-0506-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Beneficial treatment with risedronate in

Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies

✍ L. Tauchmanovà; C. Selleri; M. Esposito; C. Somma; F. Orio; G. Bifulco; S. Palom 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 208 KB

High prevalence of endocrine dysfunction

High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases

✍ Libuse Tauchmanovà; Carmine Selleri; Gennaro De Rosa; Loredana Pagano; Francesco 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

## Background: The progressively increasing number of long-term survivors after allogeneic bone marrow transplantation (allo-bmt) led researchers to focus on the early and late complications of this procedure. endocrine dysfunction occurred mostly in patients who had undergone total body irradiatio